The 4 analysts offering 12-month price forecasts for HTG Molecular Diagnostics Inc have a median target of 13.00, with a high estimate of 15.00 and a low estimate of 5.00. The median estimate represents a +180.78% increase from the last price of 4.63.
The current consensus among 4 polled investment analysts is to Buy stock in HTG Molecular Diagnostics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.98
Reporting Date May 13
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.